A groundbreaking study published in the journal “Cancers,” has brought to light a novel biological function of the Hepatocyte nuclear factor 4α (HNF4α) in DNA repair, particularly in the context of colorectal cancer (CRC) cells. This finding could have significant implications in the understanding and treatment of CRC.

The research, conducted by an adept team of scientists led by Jean-Philippe Babeu and colleagues at the Université de Sherbrooke, Canada, employed stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics, a sophisticated and precise technique, to identify proteins that interact with HNF4α.

The Unexpected Discovery of HNF4α’s Role in DNA Repair

HNF4α is a transcription factor predominantly known for its regulation of gene expression in several endoderm-derived tissues, including the liver and intestines. It plays a crucial role during organ development and has also been linked with the process of tumorigenesis. Previous studies have emphasized the liver and intestinal epithelium homeostasis regulated by HNF4α, and its involvement in the pathogenesis of several cancers including CRC.

However, this new investigation has identified a previously unrecognized association of HNF4α with cellular machinery related to DNA repair—a critical process that maintains genome stability and prevents carcinogenesis. Using advanced proteomic methodologies coupled with two different approaches, namely immunoprecipitation of GFP-HNF4α and biotin ligase BirA-based proximity-dependent purification, researchers identified an enrichment of DNA repair proteins interacting with HNF4α.

Key Proteins Interacting with HNF4α and Their Roles

Among the notable DNA repair proteins found to interact with HNF4α were PARP1, DNA-PKcs, and RAD50. PARP1 is a well-established player in the DNA damage response, and its inhibition is currently a therapeutic strategy in treating certain cancers. DNA-PKcs is part of the non-homologous end joining (NHEJ) pathway, crucial for repairing double-stranded DNA breaks. Furthermore, RAD50 is a component of the MRN complex (MRE11-RAD50-NBS1), which is pivotal in detecting DNA damage and signaling for its repair.

The Significance of HNF4α in Colorectal Cancer Cells

The interaction between these proteins and HNF4α could pave the way for enhanced cellular resistance to DNA damage. In colorectal cancer cells treated with etoposide, a chemotherapeutic drug that induces DNA breaks, the presence of HNF4α was associated with increased cell viability. This suggests that HNF4α may bolster cellular defense systems against DNA damage, an aspect that could be intricately linked to cancer cell survival and resistance to therapy.

Potential Implications for Cancer Therapy

This novel discovery enhances our understanding of CRC and carries future therapeutic implications. It suggests that targeting HNF4α could modulate the cancer cell’s ability to repair DNA, potentially rendering them more susceptible to treatment with DNA damaging agents. Additionally, it provides a foundation for exploring HNF4α as a biomarker for precision medicine approaches in CRC treatment.

Challenges and Future Directions

The study also underscores the complexity of signaling pathways and transcription factors like HNF4α, which can have diverse roles in different cellular contexts. A crucial next step is to elaborate on how HNF4α’s interaction with DNA repair proteins influences cancer cell behavior beyond survival, possibly including its impact on genomic stability, tumor progression, and metastasis.


Jean-Philippe Babeu and his team have opened a new avenue for colorectal cancer biology and treatment through their exploratory work on HNF4α. By unearthing its unforeseen role in DNA repair, they highlight the intricate network of interactions that govern cellular responses to DNA damage and the promise of innovative therapeutic strategies in the battle against cancer. Continuous research in this domain is essential to develop effective interventions and improve outcomes for patients afflicted with CRC.


1. HNF4α in DNA Repair
2. Colorectal Cancer Proteomics
3. DNA Repair Protein Interactions
4. Cancer Cell Viability and DNA Damage
5. HNF4α Transcription Factor in CRC


1. Babeu J.P., et al. Cancers (Basel). 2019;11(5):626 [DOI: 10.3390/cancers11050626].
2. Sladek F.M., et al. Genes Dev. 1990;4(12b):2353–2365 [DOI: 10.1101/gad.4.12b.2353].
3. Tanaka T., et al. J. Pathol. 2006;208(5):662–672 [DOI: 10.1002/path.1928].
4. Chen W.S., et al. Genes Dev. 1994;8(20):2466–2477 [DOI: 10.1101/gad.8.20.2466].
5. Odom D.T., et al. Science. 2004;303(5662):1378–1381 [DOI: 10.1126/science.1089769]